Drawing for EPMCELL PERFORMANCE

USPTO serial 79448039

EPMCELL PERFORMANCE

Reviewed by CopyMark Law Group

Status 641Office Action
Filing date
Status date
Registration date
—
Examiner
RIBAUDO, MICHELLE RACHEL
Law office
TMO LAW OFFICE 126

What this means

The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.

Status 641: Status 641 means the USPTO mailed a non-final Office Action identifying issues with your application. You typically have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.

Need help with EPMCELL PERFORMANCE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Office Action, set up monitoring, or talk with CopyMark.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
001Cell growth media for growing cells for use in scientific research; bacteriological culture mediums, other than for medical or veterinary purposes; cell culture reagents for scientific and research use; cultures of microorganisms, other than for medical and veterinary use; biological tissue cultures, other than for medical or veterinary purposes; biological preparation for use in cell cultures other than for medical or veterinary use; cells for scientific or laboratory purposes; stem cells, other than for medical or veterinary purposes; reagents for cell transformation.ACTIVE—
005Biological preparations for medical or veterinary purposes; reagents for extracting genetic material of microorganisms for medical or veterinary purposes; reagents for extracting genetic material in biological samples for medical or veterinary purposes; biochemical preparations for medical or veterinary purposes; chemical reagents for medical or veterinary purposes; biological and chemical reagents for medical or veterinary purposes; bacteriological culture mediums for medical purposes or veterinary purposes; surgical implants grown from stem cells [living tissues]; surgical implants derived from stem cells; liquid bandages for skin wounds; biological tissue cultures for medical purposes; cultures for medical use; stem cells for medical purposes; pharmaceutical preparations for activating cellular function.ACTIVE—
010Containers for transporting samples containing living human cells; medical instruments for interstitial thermotherapy of biological tissue; medical apparatus and instruments for cartilage restoration; apparatus for medical cell sampling; medical apparatus and instruments; apparatus for DNA and RNA testing for medical purposes; apparatus for use in medical analysis; cell testing apparatus for medical purposes; cell culture instruments for medical use; genetic testing apparatus for medical purposes; medical apparatus; apparatus for the regeneration of stem cells for medical purposes; diagnostic apparatus for medical purposes; medical skin care apparatus.ACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 20, 2026RFNTREFUSAL PROCESSED BY IB—
Aug 1, 2026RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Aug 1, 2026RFRRREFUSAL PROCESSED BY MPU—
Jun 17, 2026RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Jun 16, 2026CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 12, 2026DOCKASSIGNED TO EXAMINER—
Apr 23, 2026MAFRAPPLICATION FILING RECEIPT MAILED—
Apr 23, 2026NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Apr 16, 2026REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance